| Intrinsic Valuation of: AVGO | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 3 | Market Cap | $1,245B | |||||
| 2021 | - | - (-) | P/E Ratio | 97 | Total Asset | $166B | |||||
| 2022 | $13B | - (-) | Net Income | $6B | Total Debt | $66B | |||||
| 2023 | $16B | 22.5% (1.2%) | EBITDA | $24B | Total Liab | $98B | |||||
| 2024 | $18B | 8.1% (0.2%) | Opr Margin | 0.29 | Debt/Equity | 0.98 | |||||
| 2025 | $19B | 10.1% (-23.5%) | PreTax Margin | 21.41 | BV/Share | -15 | |||||
| 5Y Average FCF | $17B | 13.6% (-7.4%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (13.6%) | ||||||||||
| 2026 | $22B | MBG Intrinsic Value | $24 | ||||||||
| 2027 | $25B | ||||||||||
| 2028 | $28B | ||||||||||
| 2029 | $32B | ||||||||||
| 2030 | $37B | ||||||||||
| 2031 | $42B | ||||||||||
| Terminal Value | $865B | Net Worth/Share | $14 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $705B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $9B | $138 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $66B | WACC | 7.3% | 119 | 129 | 141 | 156 | 175 | |||
| Equity Value | $648B | 7.4% | 118 | 128 | 139 | 154 | 172 | ||||
| Shares Outstanding | 4,703,470,080 | 7.4% | 117 | 126 | 138 | 152 | 170 | ||||
| 7.9% | 106 | 114 | 123 | 135 | 148 | ||||||
| DCF Intrinsic Value | $138 | 8.4% | 97 | 103 | 111 | 120 | 131 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||